Jonathan Chrispin is a Cardiology physician affiliated with Johns Hopkins University. OpenAlex indexes 209 publications with 3,386 citations (h-index 32); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 N Wolfe St Ofc 1638
Baltimore, MD 212870005
Telephone
410-955-3097Provider last certified this registry record 6 Mar 2025.
Clinical trials
- Ultra High Resolution CT to Assess Role of Intramyocardial Fat and Delayed Enhancement in Ventricular Arrhythmogenesis
Sponsor: Johns Hopkins University
- Ablation at Virtual-hEart pRedicted Targets for VT
Sponsor: Johns Hopkins University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year202516 payments$16,909openpaymentsdata.cms.gov ↗
- Abbott LaboratoriesProgram year20259 payments
- AtriCure, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
68.2%Antiarrhythmic51.2%Amiodarone Hcl76%Flecainide Acetate24%Part D<11 patientsBeta blocker17.1%Metoprolol Succinate100%Part D≥13 patientsBlood & clotting
31.8%Factor Xa inhibitor31.8%Eliquis54%Xarelto46%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Multimodal AI to forecast arrhythmic death in hypertrophic cardiomyopathy
Nature Cardiovascular Research
2025 - Mechanism of Ventricular Tachycardia Occurring in Chronic Myocardial Infarction Scar
Circulation Research
2024 - Antithrombotic Therapy for Patients Undergoing Cardiac Electrophysiological and Interventional Procedures
Journal of the American College of Cardiology
2024 - Multidisciplinary Critical Care Management of Electrical Storm
Journal of the American College of Cardiology
2023 - Sex and Race Differences in Cardiac Sarcoidosis Presentation, Treatment and Outcomes
Journal of Cardiac Failure
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Roger Blumenthal, MD
Johns Hopkins University
Erin Michos, MD
Johns Hopkins University
Morgan Grams, MD
Johns Hopkins University
Mario Eisenberger, MD
Johns Hopkins University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”